Pia Vosloo

For years, the biggest hurdle for digital health and preventative care platforms wasn't consumer demand, it was reimbursement. If a digital therapeutic or continuous monitoring tool couldn't map to existing CPT insurance codes, platforms were forced to rely entirely on direct-to-consumer cash pay. That capped distribution and limited access to lower-income demographics. As regulatory frameworks and insurance coverage expand for Remote Physiological Monitoring (RPM) and digital therapies, the commercial playbook for MedTech is shifting rapidly: pmc.ncbi.nlm.nih.gov/articles/PMC... The most resilient healthtech startups are no longer just building great clinical software; they are designing reimbursement-first workflows from day one. Are you seeing more healthtech founders build around insurance integration early, or are direct-to-consumer cash models still the preferred entry point?

Following up on the discussion around human-in-the-loop AI: while keeping clinicians in the loop is essential for patient trust, it introduces a major operational challengem, clinician burnout. If an AI triage tool flags every minor anomaly for physician review, we haven't built collaborative intelligence; we’ve just built higher-volume alert fatigue. Recent implementation reviews on clinical AI stress that human-in-the-loop workflows only scale when the software handles low-complexity sorting, presenting clinicians with pre-synthesized decision contexts rather than raw data logs: pubmed.ncbi.nlm.nih.gov/41740273/ The winning MedTech platforms won't just ask doctors to validate AI outputs, they will design frictionless UI layers that make that validation take 5 seconds instead of 5 minutes. For builders in the space, how are you structuring the interface so human oversight enhances patient trust without overwhelming the care team?

Remote patient monitoring (RPM) is often sold as the ultimate bridge between clinical care and home health. But deploying connected hardware to patients' homes is only half the battle. The true challenge in RPM programs isn't device accuracy, it’s long-term user adherence. Without passive data collection or meaningful feedback loops, patient drop-off rates surge after the first 30 days. A systematic review of RPM interventions published in Nature Digital Medicine highlights that sustained clinical outcomes depend heavily on how friction-free data entry is for the patient: pmc.ncbi.nlm.nih.gov/articles/PMC... For MedTech founders, the winning RPM platforms won't just collect vitals; they will master behavioral design to keep patients actively engaged over months and years. Are you seeing RPM platforms in your ecosystem successfully solve the retention challenge, or is device abandonment still the main bottleneck?

The wearable market is flooded with continuous glucose monitors, smart rings, and biomarker tracking tools. But collecting passive data doesn't automatically translate to healthier decisions. In preventative health tech, the hardest problem isn't tracking the metric, but driving long-term behavior change. When users experience "metric fatigue," app engagement drops, and raw health data ends up sitting unused in a dashboard. Research in digital medicine emphasizes that technology must combine biomarker insights with adaptive behavior loops to achieve lasting health outcomes: www.nature.com/articles/s41... For healthtech founders, hardware and sensors are becoming commodities. The defensible value sits in behavioral design that helps users actually stick to micro-habits. Which consumer health apps do you think have mastered true behavior modification versus just offering pretty data visualizations?

There is a lot of excitement around AI triage tools and automated health coaching right now, but studying user behavior in the healthtech space reveals a consistent truth: people don't delegate their health to algorithms without human validation. When platforms try to replace the clinician entirely to cut costs, user trust and compliance drop significantly. Research into AI adoption in healthcare consistently highlights that "collaborative intelligence" and human-in-the-loop workflows yield far higher patient adherence and trust: www.nature.com/articles/s41... The highest-performing preventative health models treat technology as an amplifier for the practitioner, not a replacement. AI handles the pattern recognition in the background, but a human expert delivers the protocol. For ecosystem builders, the defensible moat in MedTech isn't purely proprietary algorithms, it’s human-centered workflows that build deep patient trust at scale. Do you think fully autonomous AI health platforms will ever overcome the trust barrier, or will the winning models always be hybrid?

I was recently auditing the digital journey for a preventative health platform, and an unexpected innovation bottleneck kept staring us in the face: data architecture. Founders building incredible tools for longevity and proactive care face a frustrating reality. The most valuable patient biomarker data remains trapped inside legacy EHR systems designed for insurance billing, not health optimization. If we want AI-driven preventative care to actually scale, the biggest breakthrough won't be a new consumer app, it will be establishing unified API standards for clinical data. For investors and builders in MedTech, the unsexy infrastructure layer is where the real leverage sits. Has anyone here seen platforms successfully solving this integration problem?